I-Mab to Release Q3 2024 Financial Results on November 14, 2024

Company Overview - I-Mab is a US-based global biotech company focused on developing highly differentiated immunotherapies for cancer treatment [3]. Financial Results Announcement - I-Mab plans to release its financial results for the third quarter ended September 30, 2024, on November 14, 2024, before the market opens [1]. - The company will not host a conference call to discuss the third quarter financial results [2]. Future Communications - I-Mab intends to hold an investor update call in conjunction with its 2024 full-year financial results to discuss its clinical pipeline, corporate strategy, and objectives [2].